Everyone 16 years or older is eligible for a vaccine.

  • Pfizer vaccine is approved for people 16 years and older.
  • Moderna and Johnson & Johnson vaccines are approved for people 18 years and older.

After a thorough safety review, the Johnson & Johnson vaccine can once again be used for anyone 18 years and older. Vaccine recipients should report any symptoms to their healthcare provider of severe headache, abdominal pain, leg pain, or shortness of breath within 3 weeks of vaccination. These adverse events appear to be extremely rare.

Where can I get a vaccine?

Follow the link below to enter your zip code and find available appointments near you.

Find a Vaccine Location

Vaccine FAQ

When will there be a vaccine for children?

The Pfizer vaccine is currently approved for ages 16 and up. We anticipate that COVID-19 vaccines will be recommended for younger children and teens also. Because children under the age of 16 were not included in the initial clinical trials, more safety testing is needed before they are allowed to receive the vaccine. The timing of when the vaccine will be available to younger age groups will depend on the results of these trials.

You can find more information from the American Academy of Pediatrics.

What are the side effects of receiving the COVID-19 vaccine?

There are currently four vaccines in development, and each will have slightly different side effects. This includes common vaccine side effects like arm soreness, fevers, and muscle aches. Many of these side effects are a sign that the immune system has been activated and the vaccine is working as intended. The vast majority of side effects are mild and temporary. It is safe to take fever reducing or pain relief medications after receiving the vaccine to treat mild side effects like a sore arm, headache, muscle aches, or low-grade fever. Since the vaccine does not contain the actual virus, it is impossible to become infected with COVID-19 through the vaccine.

The CDC and Vaccine Adverse Event Reporting System (VAERS) are continuing to monitor side effects for all receiving the vaccine. We encourage you to enroll in the V-Safe program and provide feedback about your vaccine experience when you receive your vaccine.

How long does immunity last? Will we need to get a COVID-19 vaccine yearly, similar to a flu vaccine?

We do not know how long immunity will last with the COVID-19 vaccine at this time. More information will become available over the next few months and years as the CDC gathers data and as clinical trials continue.

Do I need to continue to socially distance and wear a mask after receiving a vaccine?

Yes, current public health guidelines recommend social distancing and mask wearing practices even after receiving your second vaccine. It is not yet known whether people who are vaccinated can be asymptomatic carriers of the virus and spread it to others.

It also takes time to build immunity after receiving the vaccine. The vaccine doesn’t reach its full effectiveness until 7-14 days after the second dose. Until more people are considered immune and we have a better understanding of how long immunity lasts, the CDC recommends that all people (immunized or not) continue with preventative measures like masks and social distancing.

If I already had COVID-19 do I still need a vaccine?

Yes, you should still get the vaccine, even if you have already been infected with COVID-19. It is not clear how long natural immunity lasts and you could become reinfected with the virus. You should not get the vaccine while you have COVID-19 symptoms or are still in isolation. Current evidence suggests that patients who survive COVID-19 are unlikely to get sick again for approximately 90 days after initial infection, so it is reasonable to wait 90 days after a COVID-19 infection before being vaccinated. It is safe to receive the vaccine earlier than this 90-day period if you would like.

How do mRNA vaccines work?

What about the speed with which the vaccine was produced. Can I trust it if it came out so fast?

It is important to know that these vaccines were developed with the same safety and review process as every other vaccine we currently administer. No corners were cut.

This rapid vaccine development is really the consequence of scientists having adequate funding and building upon existing medical technologies. Global interest in vaccine development eliminated the typical financial obstacles scientists often face. Scientists were able to combine information they had about coronavirus from the SARS outbreak in 2003 with mRNA technology, already being used in cancer treatments, to develop the new vaccines.

Different administrative steps such as paperwork and vaccine production were also done in tandem with the clinical trials, allowing the vaccine to be available more quickly once it was approved. This would normally not be possible, due to barriers from red tape and financial constraints.

Should people who are pregnant or breastfeeding get the vaccine?

Pregnant and lactating women can get the vaccine, but they are encouraged to discuss this with their health care provider. None of the vaccine trials included pregnant or lactating women.

The American College of Obstetrics and Gynecology (ACOG) and Society for Maternal Fetal Medicine both recommend that pregnant and lactating women who are in high-risk professions or first responders have access to and receive the COVID-19 vaccine.

Some important considerations for those in this group:

  • We do not have enough data to establish the safety and effectiveness of the vaccine during pregnancy and lactation.
  • Though the risk of maternal or fetal harm from an mRNA vaccine is unknown, it is thought to be low. The mRNA does not enter the cell nucleus and cannot cause genetic change.
  • Pregnant women are at higher risk for more severe COVID-19 illness, so there is interest in protecting this group of individuals from infection.

Should I be concerned about having a severe allergic reaction (anaphylaxis)?

There are some reports of severe allergic reactions to a component in the vaccine. These reports are rare, so far occurring in about 1 in 200,000 patients. Patients are monitored for 15-30 minutes after receiving the vaccine, since any serious allergic reaction should occur within that timeframe. In the case of a severe allergic reaction, vaccine clinics are prepared to treat the patient on-site.

Can I get the vaccine if I have allergies?

Most people with allergies can receive the vaccine. The only restriction is in people who have had a severe reaction to the vaccine itself or any of its ingredients, including PEG (polyethylene glycol) or polysorbate. Those who have had severe allergic reactions to other vaccines or medications can still receive the vaccine, but should be monitored for 30 minutes afterwards. Other types of allergies are not a restriction to receiving the vaccine.

Should people who are immunocompromised get the vaccine?

Immunocompromised individuals are able to get the vaccine, but they are encouraged to discuss this with their health care provider. Although some patients with stable HIV infection were included in the vaccine clinical trials, we do not have enough data to establish vaccine safety and efficacy in these groups. It is especially important for immunocompromised patients to continue following current guidance on mask wearing and social distancing, even if they have received a vaccine.